Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.
about
Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation.Prophylactic Antibiotics May Improve Outcome in Patients With Severe Burns Requiring Mechanical Ventilation: Propensity Score Analysis of a Japanese Nationwide Database.Risk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study.Low-dose corticosteroid treatment and mortality in refractory abdominal septic shock after emergency laparotomy.Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study.Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction.
P2860
Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Use of recombinant human solub ...... after intestinal perforation.
@en
Use of recombinant human solub ...... after intestinal perforation.
@nl
type
label
Use of recombinant human solub ...... after intestinal perforation.
@en
Use of recombinant human solub ...... after intestinal perforation.
@nl
prefLabel
Use of recombinant human solub ...... after intestinal perforation.
@en
Use of recombinant human solub ...... after intestinal perforation.
@nl
P2860
P356
P1476
Use of recombinant human solub ...... after intestinal perforation.
@en
P2093
Hiroki Matsui
Takashi Tagami
P2860
P356
10.3389/FMED.2015.00007
P577
2015-02-26T00:00:00Z